Eingun James Song, MD, discusses growth considerations and height percentile outcomes with dupilumab in children with severe atopic dermatitis.
Bone Density in Pediatric Atopic Dermatitis: Where Does Dupilumab Fit?
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Approves Tildrakizumab for Active Psoriatic Arthritis
2
FDA Revises TB Evaluation Guidance for SKYRIZI
3
Beyond Dry Skin: Rethinking Common Eczema Misconceptions
4
How Approvals, Setbacks, and a Crowded Pipeline Are Reshaping the AD Treatment Landscape
5